Søren Nielsen2018-10-25T11:45:15+00:00

CEO of Meta-IQ

Professor Søren Nielsen MD. PhD, CEO at 2A Pharma and CEO of Meta-IQ

Professor Søren Nielsen, MD, dr.med. Aalborg University is one of the world’s leading scientists in the field of cellular/molecular biology, physiological and pathological studies of aquaporins, sodium channels and transporters with more than 380 articles published. He brings to 2A Pharma also invaluable business knowledge through Action Pharma A/S where he was co-founder and Executive (CEO 2001-2010, COO 2010-2012) and raised EUR 30 million to conduct clinical trials (Phase 2a & 2b) with AP214 – a candidate for acute renal failure – in Europe and the United States. AP214 was acquired in May 2012 by Abbott, Chicago (~ $ 110 million). For his research, he has received several awards, including the Novo Nordisk Prize, the Novo Nordisk Foundation 2009.

Direct contact

E: sn@meta-iq.com

E: sn@2apharma.com

P: +45 25 39 41 37


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.